Stock Update (NYSE:AGN): Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration

[PR Newswire] – DUBLIN and WESTLAKE VILLAGE, Calif., Aug. 5, 2015 /PRNewswire/ — Allergan plc (AGN) and KYTHERA Biopharmaceuticals, Inc. (KYTH) today announced that they have amended and restated their merger agreement with . . . → Read More: Stock Update (NYSE:AGN): Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration Similar Articles: Company Update (NYSE:AGN): Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan’s Pending Acquisition of KYTHERA Market Update (NYSE:AGN): Allergan Notes Receipt of Paragraph IV Notification on Restasis Market Update (NYSE:ACT): Actavis Announces Intention to Adopt "Allergan" Corporate Name